Difference between revisions of "Part:BBa K5133005"
 
(5 intermediate revisions by the same user not shown)
Line 13: Line 13:
 
==<b>Design and characterization</b>==
 
==<b>Design and characterization</b>==
  
−
The plasmid design of this biological part is shown as <b>Figure 1</b>, assembled with iGEM standard backbone <bbpart>pSB1C3</bbpart>. To validate the correctness of DNA sequence, result of Sanger sequencing for <bbpart>BBa_K5133006</bbpart> show the successful assembly among T7 promoter (<bbpart>BBa_K5133000</bbpart>), RBS (<bbpart>BBa_K5133001</bbpart>), Microcin H47 (this part), and T7 terminator (<bbpart>BBa_K5133003</bbpart>). (<b>Figure 2</b>).
+
The plasmid design of this biological part is shown as <b>Figure 1</b>, assembled with iGEM standard backbone <bbpart>pSB1C3</bbpart>. To validate the correctness of DNA sequence, result of Sanger sequencing for <bbpart>BBa_K5133006</bbpart> show the successful assembly among T7 promoter (<bbpart>BBa_K5133000</bbpart>), RBS (<bbpart>BBa_K5133001</bbpart>), Microcin H47 (this part), and T7 terminator (<bbpart>BBa_K5133003</bbpart>) in <b>Figure 2</b>.
  
  
Line 30: Line 30:
 
</head>
 
</head>
 
<body>
 
<body>
−
     <img src="https://static.igem.wiki/teams/5133/bba-k5133005-1.jpg"  class="resizable-img1">
+
     <img src="https://static.igem.wiki/teams/5133/bba-k5133005-11.jpg"  class="resizable-img1">
 
</body>
 
</body>
 
</html>
 
</html>
Line 55: Line 55:
 
</head>
 
</head>
 
<body>
 
<body>
−
     <img src="https://static.igem.wiki/teams/5133/bba-k5133005-2.jpg"  class="resizable-img2">
+
     <img src="https://static.igem.wiki/teams/5133/bba-k5133005-22.jpg"  class="resizable-img2">
 
</body>
 
</body>
 
</html>
 
</html>
Line 70: Line 70:
 
==<b>Usages</b>==
 
==<b>Usages</b>==
  
−
This part is used for the construction of composite part <bbpart>BBa_K5133006</bbpart> (Microcin H47 generator) to demonstrate the feasibility of <i>in vitro</i> antimicrobial peptide production by CFPS in our project.
+
This part is used for the construction of composite part <bbpart>BBa_K5133006</bbpart> (Microcin H47 generator) to demonstrate the feasibility of <i>in vitro</i> antimicrobial peptide production by CFPS. <font color="blue"><font size=4><b>Please see the detailed experimental results in <bbpart>BBa_K5133006</bbpart>.</b></font></font>
  
  
Line 79: Line 79:
 
gttggagccgtatctgccggtttgacaacagcaattggctcgaccgtgggaagtggtagtgccagttcttctgctggtggcggtagc<font color="red">catcatcatcatcatcac</font>taa
 
gttggagccgtatctgccggtttgacaacagcaattggctcgaccgtgggaagtggtagtgccagttcttctgctggtggcggtagc<font color="red">catcatcatcatcatcac</font>taa
  
−
<font color="red">Red font: 6×His-Tag, for the detection by Western-Blot analysis</font>
+
<font color="red">Red font: 6×His-Tag, for detecting the <i>in vitro</i> production of Microcin H47 by Western-Blot analysis</font>
  
  

Latest revision as of 09:08, 27 July 2024


Microcin H47

Group: GEC-China (iGEM 2024, team number: #5133)


Brief introduction

This basic part is derived from plasmid pFB399[1], including a DNA sequence for coding Microcin H47, an antimicrobial peptide produced by probiotic E. coli Nissle 1917. By assembling with T7 promoter (BBa_K5133000), RBS (BBa_K5133001), and T7 terminator (BBa_K5133003) derived from plasmid pJL1[2], this part is used for the construction of composite part BBa_K5133006 to demonstrate the in vitro production of antimicrobial peptides by CFPS.


Design and characterization

The plasmid design of this biological part is shown as Figure 1, assembled with iGEM standard backbone pSB1C3. To validate the correctness of DNA sequence, result of Sanger sequencing for BBa_K5133006 show the successful assembly among T7 promoter (BBa_K5133000), RBS (BBa_K5133001), Microcin H47 (this part), and T7 terminator (BBa_K5133003) in Figure 2.


Resizable Image


Figure 1. Schematic design of this part, generated by SnapGene.



Resizable Image


Figure 2. Validation of DNA sequence by Sanger sequencing, generated by SnapGene.




Usages

This part is used for the construction of composite part BBa_K5133006 (Microcin H47 generator) to demonstrate the feasibility of in vitro antimicrobial peptide production by CFPS. Please see the detailed experimental results in BBa_K5133006.


DNA sequence (from 5' to 3')

atgcgagaaataacagaatcacagttaagatatatttccggggcgggaggtgcgccagcgacttcagctaatgctgcaggtgctgcagctattgttggagctctcgccggaatacctggtggtccacttggggttgta gttggagccgtatctgccggtttgacaacagcaattggctcgaccgtgggaagtggtagtgccagttcttctgctggtggcggtagccatcatcatcatcatcactaa

Red font: 6×His-Tag, for detecting the in vitro production of Microcin H47 by Western-Blot analysis


References

[1] Ba, F. et al. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology. Biotechnology Journal 19, 2300327 (2024). doi: 10.1002/biot.202300327

[2] https://www.addgene.org/69496/


Sequence and Features


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal PstI site found at 74
    Illegal PstI site found at 83
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal PstI site found at 74
    Illegal PstI site found at 83
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal PstI site found at 74
    Illegal PstI site found at 83
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal PstI site found at 74
    Illegal PstI site found at 83
  • 1000
    COMPATIBLE WITH RFC[1000]